医学
免疫性血小板减少症
不利影响
质量管理
血液学
儿科
重症监护医学
梅德林
内科学
管理制度
运营管理
血小板
政治学
经济
法学
作者
Emily M. Harris,Kirsty Hillier,Michaela Nolan,Patricia Meleedy‐Rey,Taylah Buissereth,Rachael F. Grace
摘要
Despite availability of epidemiologic studies and national guidelines for the management of newly diagnosed pediatric immune thrombocytopenia (ITP), practice variation exists among and within hematology practices. We previously described the development of an ITP pathway guiding management based on bleeding symptoms. Over an 8-year period, integration of this iterative ITP pathway into management of newly diagnosed ITP increased observation rates in children with no or mild bleeding symptoms and improved consistency of laboratory evaluation and treatment strategies without increasing adverse outcomes. This quality improvement initiative has been sustainable, acceptable to providers, and increased adherence to guidelines.
科研通智能强力驱动
Strongly Powered by AbleSci AI